Company News: Page 35
Latest company news on US-listed stocks: earnings, guidance, deals, management changes and product announcements, linked to each ticker page.
Markel Group Can Offset Softer Pricing With Underwriting Discipline
Nasdaq
MKL's underwriting profitability is improving through disciplined risk selection, portfolio optimization and expense efficiency as pricing softens.
Target's Same-Day and Next-Day Units Rise Nearly 30% as Speed Improves
Nasdaq
Target's same-day and next-day units increase nearly 30% in fiscal Q2 2026 as store-based fulfillment and stronger inventory reliability improve speed.
Tesla’s Third-Quarter Deliveries Beat Expectations. Time to Buy the Stock?
Nasdaq
Key PointsTesla reported a quarterly beat in vehicle deliveries for the second quarter in a row.
Why Intel Rallied in September
Nasdaq
Key PointsIndustry news reported that Intel would be hiking PC CPU prices in October.
Is MP Stock a Buy, Hold or Sell After Its 31.2% One-Year Decline?
Nasdaq
MP Materials' steep decline, premium valuation and ongoing losses clash with its long-term magnet growth plans, raising a key question for investors.
Snowflake Stock Rallies 34% in a Year: Should You Buy, Sell, or Hold?
Nasdaq
SNOW's 34% rally reflects surging AI adoption, 37% product revenue growth and a raised fiscal 2027 outlook, even as shares trade at a premium.
CrowdStrike vs. ServiceNow: Which Technology Stock Is a Better Buy in 2026?
Nasdaq
Key PointsCrowdStrike remains a leader in cloud-native endpoint security with robust revenue growth despite past operational challenges.
BASF Expands Ultradur Portfolio With Recycled PET Grades
Nasdaq
BASFY expands Ultradur RC1 with up to 30% recycled PET, targeting high-performance automotive parts and customers' sustainability goals.
QCOM Lags Industry Year to Date: What's the Next Move for Investors?
Nasdaq
Qualcomm faces handset weakness, a faster Apple revenue drop and margin pressure, while its data-center push remains unproven amid competition.
Constellation Energy Corporation (CEG) Moves 12.3% Higher: Will This Strength Last?
Nasdaq
Constellation Energy Corporation (CEG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher…
Should You Buy, Sell or Hold SMCI Stock at a P/S Valuation of 0.41X?
Nasdaq
Super Micro Computer's discounted valuation, AI infrastructure demand, modular systems and liquid cooling support its long-term growth case despite key risks.
Own American Express By Oct. 9 to Qualify for Its Nov. 10 Dividend. Here's How Many Shares of the Warren Buffett Stock You'd Need for $1,000 in Yearly Dividends
Nasdaq
Key PointsAmerican Express has been one of Berkshire Hathaway’s best long-term compounders.
Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?
Nasdaq
Novo's semaglutide expansion into liver disease and other obesity-related conditions can unlock growth, but competition and clinical risks loom.
AbbVie's Telisotuzumab Adizutecan Secures Dual FDA Breakthrough Therapy Designations
Nasdaq
(RTTNews) - Wednesday, AbbVie Inc. (ABBV) announced that the U.S. Food and Drug Administration has granted two Breakthrough Therapy Designations for telisotuzumab adizutecan or Temab-A in colorectal…
State Street Corporation (STT) Earnings Expected to Grow: Should You Buy?
Nasdaq
State Street (STT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BlackRock (BLK) Reports Next Week: Wall Street Expects Earnings Growth
Nasdaq
BlackRock (BLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Morgan Stanley (MS) Earnings Expected to Grow: Should You Buy?
Nasdaq
Morgan Stanley (MS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold Onto Ingevity Stock for Now
Nasdaq
NGVT's portfolio reshaping, acquisitions and strong cash flow support growth, while APT weakness and macro risks cloud the outlook.
Best Momentum Stocks to Buy for October 7th
Nasdaq
MU, EQNR and OII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 7th, 2026.
Cloudflare's Data Platform Expands: Is Basin the Next Growth Driver?
Nasdaq
NET's Basin launch simplifies data management with serverless analytics, open formats and no cross-cloud transfer fees, supporting AI workloads.
Do Options Traders Know Something About Sysco Stock We Don't?
Nasdaq
Investors need to pay close attention to SYY stock based on the movements in the options market lately.
Can NVTS' Acquisition of Claros Accelerate Its AI Growth Strategy?
Nasdaq
Navitas Semiconductor's Claros acquisition adds IVR technology, strengthening its grid-to-xPU power portfolio and supporting its AI infrastructure strategy.
Wall Street Analysts Think Nvidia (NVDA) Could Surge 36.64%: Read This Before Placing a Bet
Nasdaq
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in Nvidia (NVDA). While the effectiveness of this highly sought-after metric is questionable, the…
Does Howmet (HWM) Have the Potential to Rally 40.51% as Wall Street Analysts Expect?
Nasdaq
The mean of analysts' price targets for Howmet (HWM) points to a 40.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts…
Here's Why You Should Add Phillips 66 Stock to Your Portfolio Now
Nasdaq
PSX's earnings estimates are projected to increase for 2026-27 as refining gains, stronger cash flow, lower debt and growth projects support momentum.
Is Trading Margin for Volume the Right Housing Bet for Lennar in 2026?
Nasdaq
LEN is prioritizing housing volume as affordability pressures squeeze margins, with lower costs and faster cycles supporting its strategy.
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Nasdaq
VEEV's DQS cleans clinical trial data for over 1 million subjects across 1,000+ studies, expanding automation in clinical data management.
Here's Why It is Appropriate to Invest in ITT Stock Right Now
Nasdaq
ITT's segment strength, accretive acquisitions, innovation and shareholder rewards position it for near-term growth.
Headlines and summaries belong to their publishers; links open the original article on the publisher's site. MetaCap does not republish third-party articles.
Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer